Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
5 hedge funds and large institutions have $24K invested in Artelo Biosciences, Inc. Warrant in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
118% more capital invested
Capital invested by funds: $11K → $24K (+$13K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$328 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$5K |
ARTLW Hedge Fund Activity: Q4 2020 in Review
5 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q4 2020, worth a combined $24K — up 118% from $11K a quarter earlier.
Fund positioning in ARTLW was balanced in Q4 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $328. The largest seller was CVI Holdings, exiting entirely with an estimated $5K sold.
- 5 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $24K of Artelo Biosciences, Inc. Warrant stock for Q4 2020, up 118% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q4 2020 and 1 closed out, a net change of 0 holders.
- The largest Artelo Biosciences, Inc. Warrant buyer in Q4 2020 was Susquehanna International Group, an estimated $328 added.
- The largest Artelo Biosciences, Inc. Warrant seller in Q4 2020 was CVI Holdings, an estimated $5K sold.
Based on aggregated 13F filings for Q4 2020.